Target Concentration Strategy for Cyclosporin Monitoring
- 1 March 1997
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 32 (3) , 175-179
- https://doi.org/10.2165/00003088-199732030-00001
Abstract
The target concentration concept has been proposed as a potential alternative to the established, and probably much abused, therapeutic range method of interpreting concentrations of therapeutic drugs in plasma, serum or blood when individualising drug dosages. This paper raises for debate the possibility of extending this alternative concept to immunosuppressant monitoring with cyclosporin, where there has been considerable difficulty in establishing therapeutic ranges which are widely accepted and applied. In its broader application, the target concentration strategy does present advantages to the clinician in precision, ability to calculate the dose directly from the target concentration and clearance, as well as a clearer concept of an optimal concentration (differentiating desired and adverse effects).Keywords
This publication has 16 references indexed in Scilit:
- Survey of Cyclosporine Therapeutic Ranges, Assay Methodology, and Use of 'Sparing Agents' in Australasian Transplant CentersTherapeutic Drug Monitoring, 1997
- The Use of Therapeutic Drug Monitoring to Optimise Immunosuppressive TherapyClinical Pharmacokinetics, 1996
- Lake Louise Consensus Conference on Cyclosporin Monitoring in Organ Transplantation: Report of the Consensus PanelTherapeutic Drug Monitoring, 1995
- Cyclosporin A Monitoring in AustraliaTherapeutic Drug Monitoring, 1994
- Methodological and Clinical Aspects of Cyclosporin Monitoring: Report of the Association of Clinical Biochemists Task ForceAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1994
- Theophylline Target Concentration in Severe Airways Obstruction - 10 or 20 mg/L?Clinical Pharmacokinetics, 1993
- Specific Enzyme-Multiplied Immunoassay and Fluorescence Polarization Immunoassay for Cyclosporin Compared with Cyclotrac [125I]RadioimmunoassayTherapeutic Drug Monitoring, 1992
- Canadian Consensus Meeting on cyclosporine monitoring: report of the consensus panelClinical Chemistry, 1990
- Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine.1990
- Clinical and Electroencephalographic Correlations with Serum Levels of DiphenylhydantoinArchives of Neurology, 1960